Report Detail
Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters - Medical Devices Pipeline Assessment, 2019
- RnM3864396 |
- 10 January, 2020 |
- Global |
- 211 Pages |
- GlobalData |
- Medical Devices & Consumables
Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters - Medical Devices Pipeline Assessment, 2019
Summary
GlobalData's Medical Devices sector report, “Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters - Medical Devices Pipeline Assessment, 2019" provides an overview of Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters currently in pipeline stage.
The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters pipeline products.
This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
- Extensive coverage of the Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry
Reasons to buy
The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date
Table of Contents
- 1.1 List of Tables 7
- 1.2 List of Figures 11
2 Introduction 12
- 2.1 Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters Overview 12
3 Products under Development 13
- 3.1 Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters - Pipeline Products by Stage of Development 13
- 3.2 Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters - Pipeline Products by Segment 14
- 3.3 Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters - Pipeline Products by Territory 15
- 3.4 Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters - Pipeline Products by Regulatory Path 16
- 3.5 Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters - Pipeline Products by Estimated Approval Date 17
- 3.6 Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters - Ongoing Clinical Trials 18
4 Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters - Pipeline Products under Development by Companies 19
- 4.1 Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters Companies - Pipeline Products by Stage of Development 19
- 4.2 Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters - Pipeline Products by Stage of Development 21
5 Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters Companies and Product Overview 23
- 5.1 Andramed GmbH Company Overview 23
- 5.1.1 Andramed GmbH Pipeline Products & Ongoing Clinical Trials Overview 23
- 5.2 AnGes Inc Company Overview 24
- 5.2.1 AnGes Inc Pipeline Products & Ongoing Clinical Trials Overview 24
- 5.3 AngioCure, Inc. Company Overview 25
- 5.3.1 AngioCure, Inc. Pipeline Products & Ongoing Clinical Trials Overview 25
- 5.4 Boston Scientific Corp Company Overview 26
- 5.4.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 26
- 5.5 Cagent Vascular LLC Company Overview 33
- 5.5.1 Cagent Vascular LLC Pipeline Products & Ongoing Clinical Trials Overview 33
- 5.6 Cardionovum GmbH Company Overview 36
- 5.6.1 Cardionovum GmbH Pipeline Products & Ongoing Clinical Trials Overview 36
- 5.7 Cardiovascular Systems Inc Company Overview 39
- 5.7.1 Cardiovascular Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 39
- 5.8 Concept Medical Inc Company Overview 40
- 5.8.1 Concept Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 40
- 5.9 Contego Medical LLC Company Overview 43
- 5.9.1 Contego Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 43
- 5.10 Endocor GmbH Company Overview 45
- 5.10.1 Endocor GmbH Pipeline Products & Ongoing Clinical Trials Overview 45
- 5.11 eucatech AG Company Overview 46
- 5.11.1 eucatech AG Pipeline Products & Ongoing Clinical Trials Overview 46
- 5.12 Hexacath SA Company Overview 47
- 5.12.1 Hexacath SA Pipeline Products & Ongoing Clinical Trials Overview 47
- 5.13 Lifetech Scientific (Shenzhen) Co Ltd Company Overview 48
- 5.13.1 Lifetech Scientific (Shenzhen) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 48
- 5.14 Lutonix Inc Company Overview 51
- 5.14.1 Lutonix Inc Pipeline Products & Ongoing Clinical Trials Overview 51
- 5.15 M.A. Med Alliance SA Company Overview 56
- 5.15.1 M.A. Med Alliance SA Pipeline Products & Ongoing Clinical Trials Overview 56
- 5.16 Medtronic plc Company Overview 57
- 5.16.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 57
- 5.17 Micell Technologies Inc Company Overview 61
- 5.17.1 Micell Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 61
- 5.18 MicroPort Endovascular (Shanghai) Co., Ltd. Company Overview 62
- 5.18.1 MicroPort Endovascular (Shanghai) Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview 62
- 5.19 NuVascular Technologies Inc Company Overview 65
- 5.19.1 NuVascular Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 65
- 5.20 Orchestra BioMed Inc Company Overview 66
- 5.20.1 Orchestra BioMed Inc Pipeline Products & Ongoing Clinical Trials Overview 66
- 5.21 Pulsus Medical LLC (Inactive) Company Overview 67
- 5.21.1 Pulsus Medical LLC (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 67
- 5.22 QT Vascular Ltd Company Overview 68
- 5.22.1 QT Vascular Ltd Pipeline Products & Ongoing Clinical Trials Overview 68
- 5.23 QualiMed Innovative Medizinprodukte GmbH Company Overview 72
- 5.23.1 QualiMed Innovative Medizinprodukte GmbH Pipeline Products & Ongoing Clinical Trials Overview 72
- 5.24 SiL Vascular Ltd Company Overview 73
- 5.24.1 SiL Vascular Ltd Pipeline Products & Ongoing Clinical Trials Overview 73
- 5.25 Spectranetics Corp Company Overview 74
- 5.25.1 Spectranetics Corp Pipeline Products & Ongoing Clinical Trials Overview 74
- 5.26 SurModics Inc Company Overview 81
- 5.26.1 SurModics Inc Pipeline Products & Ongoing Clinical Trials Overview 81
- 5.27 Tailored Medical Devices Inc Company Overview 90
- 5.27.1 Tailored Medical Devices Inc Pipeline Products & Ongoing Clinical Trials Overview 90
- 5.28 TransMed7 LLC Company Overview 91
- 5.28.1 TransMed7 LLC Pipeline Products & Ongoing Clinical Trials Overview 91
- 5.29 Vascular Nanotransfer Technologies Company Overview 92
- 5.29.1 Vascular Nanotransfer Technologies Pipeline Products & Ongoing Clinical Trials Overview 92
- 5.30 Zhejiang Zylox Medical Device Co Ltd Company Overview 94
- 5.30.1 Zhejiang Zylox Medical Device Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 94
6 Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters- Recent Developments 95
- 6.1 Nov 22, 2019: Medtronic receives FDA approval for IN.PACT AV DCB 95
- 6.2 Nov 19, 2019: Medtronic reports second quarter financial results for the year 2019 95
- 6.3 Nov 14, 2019: Medtronic highlights leadership in inclusion, diversity, and equity in 2019 integrated performance report 98
- 6.4 Nov 12, 2019: Cardiovascular Systems announces Stephen Stenbeck joins Board of Directors 99
- 6.5 Nov 12, 2019: Cook Medical’s leadership updates in Asia-pacific reinforce focus on growth and physician relationships 99
7 Appendix 208
- 7.1 Methodology 208
- 7.2 About GlobalData 211
- 7.3 Contact Us 211
Summary:
Get latest Market Research Reports on Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters. Industry analysis & Market Report on Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters is a syndicated market report, published as Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters - Medical Devices Pipeline Assessment, 2019. It is complete Research Study and Industry Analysis of Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
